These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 26528863

  • 21. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
    Tortelli R, Copetti M, Ruggieri M, Cortese R, Capozzo R, Leo A, D'Errico E, Mastrapasqua M, Zoccolella S, Pellegrini F, Simone IL, Logroscino G.
    Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
    [Abstract] [Full Text] [Related]

  • 22. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K.
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [Abstract] [Full Text] [Related]

  • 23. Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis.
    McCombe PA, Pfluger C, Singh P, Lim CY, Airey C, Henderson RD.
    J Neurol Sci; 2015 Apr; 353(1-2):122-9. PubMed ID: 25958264
    [Abstract] [Full Text] [Related]

  • 24. Axonal damage markers in cerebrospinal fluid are increased in ALS.
    Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H.
    Neurology; 2006 Mar 28; 66(6):852-6. PubMed ID: 16567701
    [Abstract] [Full Text] [Related]

  • 25. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E, Bedin R, Fasano A, Fini N, Gessani A, Vinceti M, Mandrioli J.
    Neurodegener Dis; 2018 Mar 28; 18(5-6):255-261. PubMed ID: 30428468
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
    Mendonça DM, Martins SC, Higashi R, Muscara MN, Neto VM, Chimelli L, Martinez AM.
    Amyotroph Lateral Scler; 2011 Mar 28; 12(2):144-7. PubMed ID: 21198418
    [Abstract] [Full Text] [Related]

  • 28. Significance of CSF NfL and tau in ALS.
    Schreiber S, Spotorno N, Schreiber F, Acosta-Cabronero J, Kaufmann J, Machts J, Debska-Vielhaber G, Garz C, Bittner D, Hensiek N, Dengler R, Petri S, Nestor PJ, Vielhaber S.
    J Neurol; 2018 Nov 28; 265(11):2633-2645. PubMed ID: 30187162
    [Abstract] [Full Text] [Related]

  • 29. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
    Wilke C, Pujol-Calderón F, Barro C, Stransky E, Blennow K, Michalak Z, Deuschle C, Jeromin A, Zetterberg H, Schüle R, Höglund K, Kuhle J, Synofzik M.
    Clin Chem Lab Med; 2019 Sep 25; 57(10):1556-1564. PubMed ID: 31251725
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
    Steinacker P, Fang L, Kuhle J, Petzold A, Tumani H, Ludolph AC, Otto M, Brettschneider J.
    PLoS One; 2011 Sep 25; 6(8):e23600. PubMed ID: 21858182
    [Abstract] [Full Text] [Related]

  • 39. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.
    Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R.
    J Neurochem; 2011 May 25; 117(3):528-37. PubMed ID: 21418221
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.